Osteoporotic (OP) fractures remain a tough clinical challenge owing to their impaired healing outcome, which requires novel biomaterials with osteogenicity for effective healing. Metallic zinc (Zn) is attracting increasing attention for biodegradable intramedullary nails (IMNs) for OP fracture healing thanks to their comprehensive mechanical properties, biosafety, and bioactivity. However, the multiple biofunctions required for OP fracture healing have not been fully met by Zn. Herein, a zoledronate (ZA)-mediated calcium-zinc silicate (Ca(Zn)Si) metal-organic/inorganic hybrid coating was fabricated on Zn-based IMN by coordination chemistry driven via interactions between ZA and Ca2+/Zn2+ as well as in-situ directional growth of Ca(Zn)Si phase. The ZA&Ca(Zn)Si hybrid coating exhibited a homogeneous micro/nanostructure with a granular morphology, which prevented premature fracture failure of IMN in rat femur by ameliorating corrosion mode and decreasing degradation rate of the Zn matrix. More importantly, this hybrid coating enabled sustained release of Zn2+/Ca2+/Si4+ and ZA in the long term, achieving a remarkable effect on vascularized bone regeneration. The coated IMN enhanced angiogenesis–osteogenesis coupling through autocrine and paracrine effects between endothelial cells and bone marrow mesenchymal stem cells. Osteoclastogenesis was repressed by Zn2+ and ZA. This approach offers a new strategy for surface-engineering of biodegradable metals for bone fracture healing.

Long-term corrosion profile of molybdenum was studied in three different simulated body fluids up to 28 days, compared with magnesium, zinc, and iron from the perspective of biodegradable metals (bio-metals). Their corrosion rate, mode, products and surface characteristics were comprehensively fathomed. Strikingly, Mo showed progressively advantageous long-term corrosion behavior with the smallest corrosion rate, and most importantly, more uniform mode, as compared with the other three bio-metals. It also performed bilaterally under the simulated inflammatory and bovine serum protein added conditions, with different corrosion progressions. These findings provide an optimistic outlook in opting molybdenum as a new type of bio-metal.

Zinc–copper (ZnCu) alloys recently showed great potential as biodegradable materials for bone implants thanks to their excellent mechanical strength, biosafety, and promising bioactivities. However, bare ZnCu alloys exhibited poor cytocompatibility and osteointegration. Moreover, the biological functions of ZnCu remain to be corroborated. Herein, the teriparatide (PTH)-mediated strontium–zinc phosphate (SrZnP) organic–inorganic hybrid coating was fabricated on the surface of ZnCu substrate via a chemical conversion method to contain the release of Zn ions and improve biofunctionality in osteogenesis. The characteristics of the hybrid coating were optimised by adjusting the amount of PTH molecules added. A dense and homogenous coating with micellar crystal micro-/nano-structure was obtained. The coated samples showed a significantly decreased corrosion rate and a more uniform corrosion mode, effectively suppressing the release of Zn2+. Additionally, the coated ZnCu enhanced the proliferation of bone marrow mesenchymal stem cells (BMSCs), promoted the expression of alkaline phosphatase and the formation of calcium nodules, and upregulated the levels of osteogenic-related genes. More important, the hybrid coating activated the classic osteogenic signalling pathway of BMP-2/Smad1/Runx2 and Sirt1/Runx2 to induce the osteogenic differentiation of BMSCs. These appealing features can be mainly attributed to the constituents of released Zn2+, Sr2+, and PTH molecules in the control, as well as the unique topographical characteristics of the coatings. Taken together, the PTH&SrZnP hybrid coating could be a promising option for surface modification of biodegradable metallic Zn for orthopaedic applications.

Braided neurovascular flow diverters (FDs) have revolutionized the treatment of aneurysms. However, dual antiplatelet therapy is mandatory for patients with FDs, which increases the risk of adverse side effects like bleeding complications. Surface modification would be of critical relevance to improve the biocompatibility and therefore clinical performance of FDs. Herein, a titanium dioxide (TiO2) covalently immobilized citric acid (CA) nanohybrid coating is fabricated on nitinol (NiTi) braided FDs by liquid phase deposition and dip-coating, to inhibit thrombosis and promote re-endothelialization. The CA molecules are covalently bound onto the pre-deposited TiO2 nanoparticulate coating. The coating has a unique homogenously nanostructured morphology as well as super-hydrophilicity. Both in vitro and in vivo results verify that the coated samples inhibit platelets and fibrinogen adhesion, delay coagulation time, and concomitantly promote re-endothelialization. Such appealing properties are ascribed to the nature of CA and TiO2 per se as well as the nanostructured morphology. The present strategy may not only provide a new avenue to surface-modify braided neurovascular FDs but also shed light on advanced nanohybrid materials for biomedical applications among others.

Zn and its alloys are receiving increasing interest for biodegradable orthopedic implant applications owing to their moderate corrosion rate and the potential functionality of Zn2+. However, their non-uniform corrosion behavior and insufficient osteogenic, anti-inflammatory, and antibacterial properties do not meet the comprehensive requirements of orthopedic implants in clinical use. Herein, an aspirin (an acetylsalicylic acid, ASA, 10, 50, 100, and 500 mg/L)-loaded carboxymethyl chitosan (CMC)/gelatin (Gel)-Zn2+ organometallic hydrogel composite coating (CMC/Gel&Zn2+/ASA) was fabricated on a Zn surface via an alternating dip-coating method, aiming to obtain a material with these comprehensive properties improved. The organometallic hydrogel composite coatings, ca. 12-16 mu m in thickness, showed compact, homogeneous, and micro-bulge structured surface morphology. The coatings protected well the Zn substrate from pitting/localized corrosion and contained the release of the bioactive components, Zn2+ and ASA, in a sustained and stable manner in long-term in vitro immersions in Hank's solution. The coated Zn showed greater ability to promote proliferation and osteogenic differentiation for MC3T3-E1 osteoblasts, and better anti-inflammatory capacity when compared with uncoated Zn. Additionally, this coating displayed excellent antibacterial activity against both Escherichia coli (>99 % antibacterial rate) and Staphylococcus aureus (>98 % antibacterial rate). Such appealing properties can be attributed to the compositional nature of the coating, namely the sustained release of Zn2+ and ASA, as well as the surface physiochemical properties because of its unique microstructure. This organometallic hydrogel composite coating can be considered a promising option for the surface modification of biodegradable Zn-based orthopedic implants among others.

Zn and its alloys are increasingly under consideration for biodegradable bone fracture fixation implants owing to their attractive biodegradability and mechanical properties. However, their clinical application is a challenge for osteoporotic bone fracture healing, due to their uneven degradation mode, burst release of zinc ions, and insufficient osteo-promotion and osteo-resorption regulating properties. In this study, a type of Zn2+ coordinated zoledronic acid (ZA) and 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) metal-organic hybrid nanostick was synthesized, which was further mixed into zinc phosphate (ZnP) solution to mediate the deposition and growth of ZnP to form a well-integrated micro-patterned metal-organic/inorganic hybrid coating on Zn. The coating protected noticeably the Zn substrate from corrosion, in particular reducing its localized occurrence as well as suppressing its Zn2+ release. Moreover, the modified Zn was osteo-compatible and osteo-promotive and, more important, performed osteogenesis in vitro and in vivo of well-balanced pro-osteoblast and anti-osteoclast responses. Such favorable functionalities are related to the nature of its bioactive components, especially the bio-functional ZA and the Zn ions it contains, as well as its unique micro- and nano-scale structure. This strategy provides not only a new avenue for surface modification of biodegradable metals but also sheds light on advanced biomaterials for osteoporotic fracture and other applications. STATEMENT OF SIGNIFICANCE: Developing appropriate biodegradable metallic materials is of clinical relevance for osteoporosis fracture healing, whereas current strategies are short of good balance between the bone formation and resorption. Here, we designed a micropatterned metal-organic nanostick mediated zinc phosphate hybrid coating modified Zn biodegradable metal to fulfill such a balanced osteogenicity. The in vitro assays verified the coated Zn demonstrated outstanding pro-osteoblasts and anti-osteoclasts properties and the coated intramedullary nail promoted fracture healing well in an osteoporotic femur fracture rat model. Our strategy may offer not only a new avenue for surface modification of biodegradable metals but also shed light on better understanding of new advanced biomaterials for orthopedic application among others.